Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The main goal of this randomized clinical trial called ePro-schools project is to co-design and test the effectiveness of an eHealth platform for promoting healthy habits among adolescents from socially disadvantaged settings. The main questions it aims to answer is:
Researchers will compare a web page with all the contents of the ePro-Schools program through the online platform who participants in the intervention group will have access, to a web page with basic information about health-related habits (healthy eating and physical activity) who participants in the control group will have access, to see if ePro-School program improve physical activity levels and dietary habits in adolescents from socially disadvantaged backgrounds.
Participants will:
Full description
There is limited high-quality information regarding physical activity, sedentary behaviour and dietary habits focusing on adolescents from socially disadvantaged settings. Therefore, there is a limited number of public health and educational policies specifically designed for this population group. The ePro-Schools project will address both knowledge gaps in the state-of the-art by co-designing and testing the effectiveness of an intervention, which includes an eHealth platform (website), for promoting healthy habits among adolescents from socially disadvantaged settings in the area of Central Catalonia. For this reason, the main aim of the ePro-Schools project is to co-design and test the effectiveness of an eHealth platform for promoting healthy habits among adolescents from socially disadvantaged settings. The specific objectives of the project are to:
The study will be conducted in the area of Central Catalonia, particularly in six secondary schools from socially disadvantaged settings (intervention group vs control group size ratio 1:1). We will focus on students attending 1st and 2nd of secondary school and in total around 1000 adolescents will be involved. Moreover, physical activity teachers from the selected secondary schools will participate in the study as well (co-creation process and by answering some questionnaires).
To achieve all the objectives, the project has several phases:
In the same line, we propose de following analysis. First, an implementation analysis will be carried out. These focus on evaluating the adoption, acceptability, appropriateness, and feasibility of the program. Adoption will be assessed through multiple indicators, such as questionnaire completion and content interaction, instead of just logins or time spent on the platform. Acceptability and feasibility will be evaluated using questionnaires, interviews, and focus groups during the co-creation phase. Barriers and facilitators to implementation will also be explored, and all qualitative data will be recorded, transcribed, and analyzed.
Moreover, an effectiveness and cost-effectiveness analysis will be carried out. First, a statistical analyses will assess the impact of the program using Mixed Methods with Repeated Measurements (MMRM) for continuous data and Generalized Estimating Equations (GEE) for categorical data. The analyses will measure outcomes at both post-intervention and follow-up, adjusting for sex, sociodemographic status, and baseline outcomes. Effect size will be calculated using Cohen's coefficient and the Reliable Change Index (RCI) will measure reliable results. Second, a comparison of costs between the new intervention and regular care will be made, calculating the incremental cost-effectiveness ratio (ICER). The cost-effectiveness will be expressed as cost per Quality-Adjusted Life Year (QALY) gained. Data will be used in a Health Technology Assessment (HTA) to evaluate economic, organizational, and ethical aspects of the intervention.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adolescents:
Physical activity teachers:
Exclusion criteria
Adolescents:
Physical activity teachers:
Primary purpose
Allocation
Interventional model
Masking
1,000 participants in 2 patient groups
Loading...
Central trial contact
Josep Vidal-Alaball, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal